{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:55:46Z","timestamp":1783475746260,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004887","name":"Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["96-01-92-34801"],"award-info":[{"award-number":["96-01-92-34801"]}],"id":[{"id":"10.13039\/501100004887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11030-019-10008-x","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T09:39:35Z","timestamp":1576575575000},"page":"997-1013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors"],"prefix":"10.1007","volume":"24","author":[{"given":"Mehrdad","family":"Mehrazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Hassankalhori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Toolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Nadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nasir Abbas","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loghman","family":"Firoozpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5611","authenticated-orcid":false,"given":"Alireza","family":"Foroumadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"10008_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2015","unstructured":"Reitz C, Mayeux R (2015) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640\u2013651. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.024","journal-title":"Biochem Pharmacol"},{"key":"10008_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a006239","volume":"2","author":"R Mayeux","year":"2012","unstructured":"Mayeux R, Stern Y (2012) Epidemiology of alzheimer disease. Cold Spring Harb Perspect Med 2:1\u201318. https:\/\/doi.org\/10.1101\/cshperspect.a006239","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10008_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2012","unstructured":"Reitz C, Brayne C, Mayeux R (2012) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137\u2013152. https:\/\/doi.org\/10.1038\/nrneurol.2011.2","journal-title":"Nat Rev Neurol"},{"key":"10008_CR4","first-page":"24","volume":"4","author":"IO Korolev","year":"2014","unstructured":"Korolev IO (2014) Alzheimer\u2019s disease: a clinical and basic science review. Med Stud Res J 4:24\u201333","journal-title":"Med Stud Res J"},{"key":"10008_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/bmj.b158","volume":"338","author":"A Burns","year":"2009","unstructured":"Burns A, Iliffe S (2009) Alzheimer\u2019s disease. BMJ 338:467\u2013471. https:\/\/doi.org\/10.1136\/bmj.b158","journal-title":"BMJ"},{"key":"10008_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"30","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, De Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 30:505\u2013517. https:\/\/doi.org\/10.1016\/S0140-6736(15)01124-1","journal-title":"Lancet"},{"key":"10008_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"10008_CR8","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1021\/jm3017317","volume":"56","author":"B Bulic","year":"2013","unstructured":"Bulic B, Pickhardt M, Mandelkow E (2013) Progress and developments in tau aggregation inhibitors for alzheimer disease. J Med Chem 56:4135\u20134155. https:\/\/doi.org\/10.1021\/jm3017317","journal-title":"J Med Chem"},{"key":"10008_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/b978-0-12-802173-6.00002-2","volume-title":"Developing therapeutics for Alzheimer\u2019s disease","author":"B Hooli","year":"2016","unstructured":"Hooli B, Tanzi RE (2016) The genetic basis of Alzheimer\u2019s disease. In: Wolfe MS (ed) Developing therapeutics for Alzheimer\u2019s disease. Academic Press, Cambridge, pp 23\u201337. https:\/\/doi.org\/10.1016\/b978-0-12-802173-6.00002-2"},{"key":"10008_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40266-015-0266-9","volume":"32","author":"JS Buckley","year":"2015","unstructured":"Buckley JS, Salpeter SR (2015) A risk-benefit assessment of dementia medications: systematic review of the evidence. Drugs Aging 32:453\u2013467. https:\/\/doi.org\/10.1007\/s40266-015-0266-9","journal-title":"Drugs Aging"},{"key":"10008_CR11","doi-asserted-by":"publisher","first-page":"CD005593","DOI":"10.1002\/14651858.cd005593","volume":"1","author":"J Birks","year":"2006","unstructured":"Birks J (2006) Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev 1:CD005593. https:\/\/doi.org\/10.1002\/14651858.cd005593","journal-title":"Cochrane Database Syst Rev"},{"key":"10008_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1755-5949.2010.00175.x","volume":"16","author":"A Martorana","year":"2010","unstructured":"Martorana A, Esposito Z, Koch G (2010) Beyond the cholinergic hypothesis: do current drugs work in Alzheimer\u2019s disease? CNS Neurosci Ther 16:235\u2013245. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00175.x","journal-title":"CNS Neurosci Ther"},{"key":"10008_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S1461145705005833","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9:101\u2013124. https:\/\/doi.org\/10.1017\/S1461145705005833","journal-title":"Int J Neuropsychopharmacol"},{"key":"10008_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge O (2015) Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 148:34\u201346. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.011","journal-title":"Pharmacol Ther"},{"key":"10008_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","volume":"221","author":"A Contestabile","year":"2011","unstructured":"Contestabile A (2011) The history of the cholinergic hypothesis. Behav Brain Res 221:334\u2013340. https:\/\/doi.org\/10.1016\/j.bbr.2009.12.044","journal-title":"Behav Brain Res"},{"key":"10008_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","volume":"6","author":"A Schmitz","year":"2016","unstructured":"Schmitz A (2016) Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin 6:120\u2013126. https:\/\/doi.org\/10.9740\/mhc.2016.05.120","journal-title":"Ment Health Clin"},{"key":"10008_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1023\/A:1007500424392","volume":"25","author":"MRC Schetinger","year":"2000","unstructured":"Schetinger MRC, Porto NM, Moretto MB, Morsch VM, Da Rocha JBT, Vieira V, Moro F, Neis RT, Bittencourt S, Bonacorso HG et al (2000) New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochem Res 25:949\u2013955. https:\/\/doi.org\/10.1023\/A:1007500424392","journal-title":"Neurochem Res"},{"key":"10008_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1570193X14666170511121927","volume":"14","author":"V Shweta","year":"2017","unstructured":"Shweta V, Sushil K (2017) A mini review on synthetic approaches and biological activities of benzodiazepines. Mini Rev Org Chem 14:453\u2013468. https:\/\/doi.org\/10.2174\/1570193X14666170511121927","journal-title":"Mini Rev Org Chem"},{"key":"10008_CR19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.7164\/antibiotics.49.742","volume":"49","author":"F Kuno","year":"1996","unstructured":"Kuno F, Otoguro K, Shiomi K, Iwai Y, Omura S (1996) Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259. J Antibiot Tokyo 49:742\u2013747","journal-title":"J Antibiot Tokyo"},{"key":"10008_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s12272-012-0806-3","volume":"35","author":"L Mohamed","year":"2012","unstructured":"Mohamed L (2012) Design and synthesis of novel 1,4-benzodiazepine derivatives and their biological evaluation as cholinesterase inhibitors. Arch Pharm Res 35:1369\u20131377. https:\/\/doi.org\/10.1007\/s12272-012-0806-3","journal-title":"Arch Pharm Res"},{"key":"10008_CR21","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1021\/acs.chemrev.5b00408","volume":"116","author":"VK Tiwari","year":"2016","unstructured":"Tiwari VK, Mishra BB, Mishra KB, Mishra N, Singh AS, Chen X (2016) Cu-catalyzed click reaction in carbohydrate chemistry. Chem Rev 116:3086\u20133240. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00408","journal-title":"Chem Rev"},{"key":"10008_CR22","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb HC, Finn MG, Sharpless KB (2001) Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed 40:2004\u20132021. https:\/\/doi.org\/10.1002\/1521-3773(20010601)40:11%3c2004:AID-ANIE2004%3e3.0.CO;2-5","journal-title":"Angew Chem Int Ed"},{"key":"10008_CR23","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1021\/cr0783479","volume":"108","author":"M Meldal","year":"2008","unstructured":"Meldal M, Tornoe CW (2008) Cu-catalyzed azide-alkyne cycloaddition. Chem Rev 108:2952\u20133015. https:\/\/doi.org\/10.1021\/cr0783479","journal-title":"Chem Rev"},{"key":"10008_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ejmech.2015.01.044","volume":"6","author":"M Mohammadi-Khanaposhtani","year":"2015","unstructured":"Mohammadi-Khanaposhtani M, Saeedi M, Zafarghandi NS, Mahdavi M, Sabourian R, Razkenari EK, Alinezhad H, Khanavi M, Foroumadi A, Shafiee A, Akbarzadeh T (2015) Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives. Eur J Med Chem 6:799\u2013806. https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.044","journal-title":"Eur J Med Chem"},{"key":"10008_CR25","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1016\/j.bmcl.2016.07.017","volume":"26","author":"JC Li","year":"2016","unstructured":"Li JC, Zhang J, Rodrigues MC, Ding DJ, Longo JP, Azevedo RB, Muehlmann LA, Jiang CS (2016) Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity. Bioorg Med Chem Lett 26:3881\u20133885. https:\/\/doi.org\/10.1016\/j.bmcl.2016.07.017","journal-title":"Bioorg Med Chem Lett"},{"key":"10008_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1039\/C7MD00457E","volume":"9","author":"G Wu","year":"2018","unstructured":"Wu G, Gao Y, Kang D, Huang B, Huo Z, Liu H, Poongavanam V, Zhan P, Liu X (2018) Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors. Med Chem Commun 9:149\u2013159. https:\/\/doi.org\/10.1039\/C7MD00457E","journal-title":"Med Chem Commun"},{"key":"10008_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccr.2016.02.010","volume":"316","author":"C Wang","year":"2016","unstructured":"Wang C, Ikhlef D, Kahlal S, Saillar J-Y, Astruc D (2016) Metal-catalyzed azide-alkyne \u201cclick\u201d reactions: mechanistic overview and recent trends. Coord Chem Rev 316:1\u201320. https:\/\/doi.org\/10.1016\/j.ccr.2016.02.010","journal-title":"Coord Chem Rev"},{"key":"10008_CR28","doi-asserted-by":"publisher","first-page":"28838","DOI":"10.1039\/C5RA27275K","volume":"6","author":"M Mahdavi","year":"2016","unstructured":"Mahdavi M, Lijan H, Bahadorikhalili S, Ma\u2019mani L, Ranjbar PR, Shafiee A (2016) Copper supported \u03b2-cyclodextrin grafted magnetic nanoparticles as an efficient recyclable catalyst for one-pot synthesis of 1-benzyl-1H-1,2,3-triazoldibenzodiazepinone derivatives via click reaction. RSC Adv 6:28838\u201328843","journal-title":"RSC Adv"},{"key":"10008_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ejmech.2019.07.059","volume":"180","author":"M Xu","year":"2019","unstructured":"Xu M, Peng Y, Zhu L, Wang S, Ji KJ, Rakesh P (2019) Triazole derivatives as inhibitors of Alzheimer\u2019s disease: current developments and structure-activity relationships. Eur J Med Chem 180:656\u2013672. https:\/\/doi.org\/10.1016\/j.ejmech.2019.07.059","journal-title":"Eur J Med Chem"},{"key":"10008_CR30","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1002\/asia.20110043","volume":"6","author":"SG Agalave","year":"2011","unstructured":"Agalave SG, Maujan SR, Pore VS (2011) Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J 6:2696\u20132718. https:\/\/doi.org\/10.1002\/asia.20110043","journal-title":"Chem Asian J"},{"key":"10008_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.drudis.2015.08.004","volume":"21","author":"X Wang","year":"2016","unstructured":"Wang X, Huang B, Liu X, Zhan P (2016) Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries. Drug Discov Today 21:118\u2013132. https:\/\/doi.org\/10.1016\/j.drudis.2015.08.004","journal-title":"Drug Discov Today"},{"key":"10008_CR32","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","volume":"27","author":"K Bozorova","year":"2019","unstructured":"Bozorova K, Zhaoa J, Haji A (2019) 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent Overview. Bioorg Med Chem 27:3511\u20133531. https:\/\/doi.org\/10.1016\/j.bmc.2019.07.005","journal-title":"Bioorg Med Chem"},{"key":"10008_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bioorg.2018.04.030","volume":"79","author":"L Jalili-Baleh","year":"2018","unstructured":"Jalili-Baleh L, Nadri H, Forootanfar H, Samzadeh-Kermani A, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Ayazgok B, Rahimifard M, Baeeri M, Doostmohammadi M, Firoozpour L et al (2018) Novel 3-phenylcoumarin\u2013lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer\u2019s disease. Bioorg Chem 79:223\u2013234. https:\/\/doi.org\/10.1016\/j.bioorg.2018.04.030","journal-title":"Bioorg Chem"},{"key":"10008_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bioorg.2018.06.006","volume":"80","author":"F Abedinifar","year":"2018","unstructured":"Abedinifar F, Farnia SMF, Mahdavi M, Nadri H, Moradi A, Ghasemi JB, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Firoozpour L, Foroumadi A (2018) Synthesis and cholinesterase inhibitory activity of new 2-benzofuran carboxamide-benzylpyridinum salts. Bioorg Chem 80:180\u2013188. https:\/\/doi.org\/10.1016\/j.bioorg.2018.06.006","journal-title":"Bioorg Chem"},{"key":"10008_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bioorg.2018.11.010","volume":"83","author":"N Salehi","year":"2019","unstructured":"Salehi N, Mirjalili BBF, Nadri H, Abdolahi Z, Forootanfar H, Samzadeh-Kermani A, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Ayazgok B, Emami S, Haririan I, Sharifzadeh M, Foroumadi A et al (2019) Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer\u2019s agents. Bioorg Chem 83:559\u2013568. https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.010","journal-title":"Bioorg Chem"},{"key":"10008_CR36","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00044-018-2187-8","volume":"27","author":"A Moradi","year":"2018","unstructured":"Moradi A, Faraji L, Nadri H, Hasanpour Z, Moghadam FH, Pakseresht B, Golshani M, Moghimi S, Ramazani A, Firoozpour L et al (2018) Synthesis, docking study, and biological evaluation of novel umbellipherone\/hymecromone derivatives as acetylcholinesterase\/butyrylcholinesterase inhibitors. Med Chem Res 27:1741\u20131747. https:\/\/doi.org\/10.1007\/s00044-018-2187-8","journal-title":"Med Chem Res"},{"key":"10008_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/cbdd.12902","volume":"89","author":"B Pouramiri","year":"2017","unstructured":"Pouramiri B, Moghimi S, Mahdavi M, Nadri H, Moradi A, Tavakolinejad-Kermani E, Firoozpour L, Asadipour A, Foroumadi A (2017) Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives. Chem Biol Drug Des 89:783\u2013789. https:\/\/doi.org\/10.1111\/cbdd.12902","journal-title":"Chem Biol Drug Des"},{"key":"10008_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2161-0401.1000173","volume":"5","author":"M Asif","year":"2016","unstructured":"Asif M (2016) Biological potentials of biological active triazole derivatives: a short review. Org Chem Curr Res 5:2\u20139. https:\/\/doi.org\/10.4172\/2161-0401.1000173","journal-title":"Org Chem Curr Res"},{"key":"10008_CR39","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.bmcl.2009.03.035","volume":"19","author":"D McGowan","year":"2009","unstructured":"McGowan D, Nyanguile O, Cummings MD, Vendeville S, Vandyck K, Van den Broeck W, Boutton CW, De Bondt H, Quirynen L, Amssoms K et al (2009) 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase. Bioorg Med Chem Lett 19:2492\u20132496. https:\/\/doi.org\/10.1016\/j.bmcl.2009.03.035","journal-title":"Bioorg Med Chem Lett"},{"key":"10008_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1134\/S1070428011030146","volume":"47","author":"NA Vatolina","year":"2011","unstructured":"Vatolina NA, Andin AN (2011) Reactions of dimedone-\u03b2-benzoylacrylic acid adduct with nitrogen-containing binucleophiles. Russ J Org Chem 47:408\u2013411. https:\/\/doi.org\/10.1134\/S1070428011030146","journal-title":"Russ J Org Chem"},{"key":"10008_CR41","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1039\/C7NJ05185A","volume":"42","author":"HMT Albuquerque","year":"2018","unstructured":"Albuquerque HMT, Santos CMM, Cavaleiro JAS, Silva AMS (2018) First intramolecular Diels\u2013Alder reactions using chromone derivatives: synthesis of chromeno[3,4-b]xanthones and 2-(benzo[c]chromenyl)chromones. New J Chem 42:4251\u20134260. https:\/\/doi.org\/10.1039\/C7NJ05185A","journal-title":"New J Chem"},{"key":"10008_CR42","doi-asserted-by":"publisher","first-page":"13228","DOI":"10.1021\/acs.joc.8b01928","volume":"83","author":"N Yesilgul","year":"2018","unstructured":"Yesilgul N, Seven O, Guliyev R, Akkaya EU (2018) Energy harvesting in a bodipy-functionalized rotaxane. J Org Chem 83:13228\u201313232. https:\/\/doi.org\/10.1021\/acs.joc.8b01928","journal-title":"J Org Chem"},{"key":"10008_CR43","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.bmcl.2009.12.062","volume":"20","author":"RH Hans","year":"2010","unstructured":"Hans RH, Guantai EM, Lategan C, Smith PJ, Wan B, Franzblau SG, Gut J, Rosenthal PJ, Chibale K (2010) Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorg Med Chem Lett 20:942\u2013944. https:\/\/doi.org\/10.1016\/j.bmcl.2009.12.062","journal-title":"Bioorg Med Chem Lett"},{"key":"10008_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andresjr V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"10008_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"10008_CR46","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"16","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner M, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and Auto DockTools4: automated docking with selective receptor flexibility. J Comput Chem 16:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"10008_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H Levine","year":"1993","unstructured":"Levine H (1993) Thioflavine T interaction with synthetic Alzheimer\u2019s disease \u03b2-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404\u2013410. https:\/\/doi.org\/10.1002\/pro.5560020312","journal-title":"Protein Sci"},{"key":"10008_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0975-9476.140474","volume":"5","author":"A Mandegary","year":"2014","unstructured":"Mandegary A, Soodi M, Sharififar F, Ahmadi S (2014) Anticholinesterase, antioxidant, and Neuroprotective effects of Tripleurospermum disciforme and Dracocephalum multicaule. J Ayurveda Integr Med 5:162\u2013166. https:\/\/doi.org\/10.4103\/0975-9476.140474","journal-title":"J Ayurveda Integr Med"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-10008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-019-10008-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-10008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T01:01:44Z","timestamp":1608080504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-019-10008-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10008"],"URL":"https:\/\/doi.org\/10.1007\/s11030-019-10008-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}